Galectin-3, a novel binding partner of β-catenin

Cancer Research

Volumn 64, Issue 18, 2004, Pages 6363-6367

  Shimura, Tatsuo ^a,c   Takenaka, Yukinori ^a   Tsutsumi, Souichi ^a,c   Hogan, Victor ^a   Kikuchi, Akira ^b   Raz, Avraham ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HIROSHIMA UNIVERSITY   (Japan)

^c GUNMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BETA CATENIN; CYCLIN D1; GALECTIN 3; MYC PROTEIN; T CELL FACTOR PROTEIN; T CELL FACTOR PROTEIN 4; UNCLASSIFIED DRUG; WNT PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CELL NUCLEUS; CONTROLLED STUDY; CYTOSOL; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; METASTASIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; REPORTER GENE; SIGNAL TRANSDUCTION;

BETA CATENIN; BREAST NEOPLASMS; CELL LINE, TUMOR; CYTOSKELETAL PROTEINS; DNA-BINDING PROTEINS; GALECTIN 3; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, BCL-1; HCT116 CELLS; HT29 CELLS; HUMANS; PLASMIDS; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; TCF TRANSCRIPTION FACTORS; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSFECTION; UP-REGULATION;

EID: 4644308447     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-1816     Document Type: Article

References (20)

1. Wodarz A, Nusse R. Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol 1998;14:59-88.
2. 2+ pathways. Oncogene 1999;18:7860-72.
3. Huelsken J, Vogel R, Brinkmann V, et al. Requirement for β-catenin in anterior-posterior axis formation in mice. J Cell Biol 2000;148:567-78.
4. Behrens J, Jerchow B-A, Würtele M, et al. Functional interaction of an axin homolog, conductin, with β-catenin, APC, and GSK3β. Science 1998;280:596-9.
5. Ikeda S, Kishida S, Yamamoto H, et al. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3β and β-catenin and promotes GSK-3β-dependent phosphorylation of β-catenin. EMBO J 1998;17:1371-84.
6. Kikuchi A. Roles of Axin in the Wnt signaling pathway. Cell Signalling 1999;11:777-88.
7. Shtutman M, Zhurinsky J, Simcha I, et al. The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway. Proc Natl Acad Sci USA 1999;96:5522-7.
8. Tetsu O, McCormick F. β-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999;398:422-6.
9. Hughes RC. The galectin family of mammalian carbohydrate-binding molecules. Biochem Soc Trans 1997;25:1194-8.
10. Akahani S, Nangia-Makker P, Inohara H, et al. Galectin-3: a novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family. Cancer Res 1997;57:5272-6.
11. Danguy A, Camby I, Kiss R. Galectins and cancer. Biochim Biophys Acta 2000;19:285-93.
12. Davidson PJ, Davis MJ, Patterson RJ, et al. Shuttling of galectin-3 between the nucleus and cytoplasm. Glycobiology 2002;12:329-37.
13. Lin H-M, Pestell RG, Raz A, Kim HRC. Galectin-3 enhances cyclin D1 promoter activity through SP1 and a cAMP-responsive element in human breast epithelial cells. Oncogene 2002;21:8001-10.
14. Lotz MM, Andrews CW Jr, Korzelius CA, et al. Decreased expression of Mac-2 (carbohydrate binding protein 35) and loss of its nuclear localization are associated with the neoplastic progression of colon carcinoma. Proc Natl Acad Sci USA 1993;90:3466-70.
15. Honjo Y, Inohara H, Akahani S, et al. Expression of cytoplasmic galectin-3 as a prognostic marker in tongue carcinoma. Clin Cancer Res 2000;6:4635-40.
16. Van den Brule FA, Waltregny D, et al. Alteration of the cytoplasmic/nuclear expression pattern of galectin-3 correlates with prostate carcinoma progression. Int J Cancer 2000;89:361-7.
17. Nangia-Makker P, Hogan V, Honjo Y, et al. Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectin. J Natl Cancer Inst (Bethesda) 2002;94:1854-62.
18. Umar S, Morris AP, Kourouma F, Sellin JH (2003) Dietary pectin and calcium inhibit colonic proliferation in vivo by differing mechanisms. Cell Prolif 2003;36:361-75.
19. Fagotto F, Gluck U, Gumbiner BM. Nuclear localization signal-independent and importin/karyopherin-independent nuclear import of β-catenin. Curr Biol 1998;8:181-90.
20. Aoki M, Sobek V, Maslyar DJ, et al. Oncogenic transformation by β-catenin: deletion analysis and characterization of selected target genes. Oncogene 2002;21:6983-91.